REPROCELL

REPROCELL is a Contract Research Organization (CRO). It provides a unique combination of products and services to power your translational research. With scientists and laboratories across three continents, we possess scientific and clinical expertise to better translate your discoveries into therapeutic solutions. Based on its expertise in pluripotent stem cells and mesenchymal stem cells, REPROCELL is also developing novel regenerative medicine therapies for neurodegenerative diseases, currently conducting clinical trials in Japan for the treatment of Spinocerebellar Ataxia. Its diagnostic services and clinical research services are offered in laboratories in Japan, the United States, the United Kingdom, and India.